Cargando…
Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin
Autores principales: | Watanabe, Kageaki, Kitadai, Rui, Kitagawa, Shingo, Toya, Takashi, Hosomi, Yukio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474194/ https://www.ncbi.nlm.nih.gov/pubmed/34589942 http://dx.doi.org/10.1016/j.jtocrr.2020.100046 |
Ejemplares similares
-
Pure red cell aplasia associated with autoimmune hepatitis successfully treated with cyclosporine A
por: Sato, Akira, et al.
Publicado: (2014) -
Pure red cell aplasia accompanied by COVID-19 successfully treated using cyclosporine
por: Yamazaki, Susumu, et al.
Publicado: (2022) -
Case Report: Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor-Related Pure Red Cell Aplasia With Cyclosporin
por: Gérard, Alexandre, et al.
Publicado: (2020) -
Secondary pure red cell aplasia in multiple myeloma treated with lenalidomide
por: Ito, Tomoki, et al.
Publicado: (2018) -
Pembrolizumab-induced Pure Red Cell Aplasia Successfully Treated with Intravenous Immunoglobulin
por: Isoda, Atsushi, et al.
Publicado: (2020)